Points to Consider on the Non-Clinical Safety Evaluation of Anticancer Drugs

Journal of Toxicological Sciences - Japan
doi 10.2131/jts.33.123
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Toxicology

Related search

Conducting Clinical Trials in Outbreak Settings: Points to Consider

Clinical Trials
MedicinePharmacology
2016English

Evaluation of Anticancer Drugs by Lymphocyte Electrophoresis.

Journal of Pharmacobio-Dynamics
1986English

Clinical Practice Guidelines for Translating Pharmacogenomic Knowledge to Bedside. Focus on Anticancer Drugs

Frontiers in Pharmacology
Pharmacology
2014English

Anti-Ku Antibodies: Important Points to Consider

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2019English

In Vitro Human Cell Line Models to Predict Clinical Response to Anticancer Drugs

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2015English

The Evaluation of Comprehensive Countermeasures to Reduce Occupational Exposure to Anticancer Drugs During Preparation and Administration

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2013English

Cognitive Training With Casual Video Games: Points to Consider

Frontiers in Psychology
Psychology
2014English

A Study on the Sensitivity Test of Cancer Cells to Anticancer Drugs

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1966English

Points to Consider When Self-Assessing Your Empirical Accounting Research

Contemporary Accounting Research
AccountingEconomicsEconometricsFinance
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy